Dose and Plasma Concentration of Galantamine in Alzheimer's Disease - Clinical Application
Alzheimer's Research and Therapy - United Kingdom
doi 10.1186/alzrt156
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Springer Science and Business Media LLC